Palliative oncology and palliative care.
early integration
oncology
palliative care services
personalized medicine
quality-of-life
translational research
Journal
Molecular oncology
ISSN: 1878-0261
Titre abrégé: Mol Oncol
Pays: United States
ID NLM: 101308230
Informations de publication
Date de publication:
10 2022
10 2022
Historique:
revised:
23
05
2022
received:
04
03
2022
accepted:
25
06
2022
pubmed:
29
6
2022
medline:
7
10
2022
entrez:
28
6
2022
Statut:
ppublish
Résumé
New therapeutic approaches can produce promising results even in severely ill cancer patients. But they also pose new challenges with respect to prognostication, as patients who were once not eligible for treatment, due to age or comorbidities, now are. Palliative oncology constitutes a major part of oncological care, with life prolongation and quality of life as its main goals. Palliative care specialists are experts in symptom control and psychosocial and existential support, and the integration of their expertise early on in patient care can prolong survival. In this article, I discuss the need to integrate specialist palliative care into early cancer treatment plans to achieve quality of life for patients. I also discuss the ways in which palliative care specialists balance the benefits of novel treatments against their adverse effects for patients, particularly for the elderly, the frail and those in advance stages of disease. I highlight the need to ensure equal access to palliative care to improve cancer patients' quality of life but also why futile, burdensome treatments should be avoided especially in the frail, elderly patients. Further, I discuss benefits and problems related to nutritional support in patients with cachexia and exemplify why translational research is needed to link basic research with clinical oncology and effective symptom control.
Identifiants
pubmed: 35762045
doi: 10.1002/1878-0261.13278
pmc: PMC9533690
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
3399-3409Informations de copyright
© 2022 The Authors. Molecular Oncology published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies.
Références
Dermatol Ther (Heidelb). 2021 Oct;11(5):1481-1496
pubmed: 34339016
Signal Transduct Target Ther. 2020 Jun 18;5(1):99
pubmed: 32555170
Cancer Manag Res. 2020 Jul 09;12:5597-5605
pubmed: 32753972
Cochrane Database Syst Rev. 2018 Feb 06;2:CD011123
pubmed: 29405038
Crit Care Clin. 2021 Jan;37(1):1-18
pubmed: 33190763
J Natl Cancer Inst. 2011 Jan 19;103(2):117-28
pubmed: 21228314
J Pain Symptom Manage. 2019 Apr;57(4):746-752
pubmed: 30639732
Mol Oncol. 2017 Dec;11(12):1661-1672
pubmed: 29024497
N Engl J Med. 2010 Aug 19;363(8):733-42
pubmed: 20818875
Front Public Health. 2016 Aug 02;4:159
pubmed: 27532034
JAMA Oncol. 2015 Sep;1(6):778-84
pubmed: 26203912
Acta Oncol. 2017 Oct;56(10):1258-1264
pubmed: 28578604
J Immunol Res. 2020 Jun 28;2020:9235638
pubmed: 32671117
Ann Oncol. 2017 Apr 1;28(4):809-817
pubmed: 27993817
Lancet Oncol. 2011 May;12(5):489-95
pubmed: 21296615
Surg Today. 2021 Feb;51(2):204-211
pubmed: 32857252
Pain. 2011 Nov;152(11):2564-2574
pubmed: 21907491
J Immunother Cancer. 2019 May 22;7(1):134
pubmed: 31118078
J Pain Symptom Manage. 2009 Jan;37(1):13-22
pubmed: 18676119
Nutrition. 2020 Nov - Dec;79-80:110945
pubmed: 32927241
Palliat Med. 2014 Feb;28(2):101-10
pubmed: 23703237
J Natl Cancer Inst. 2014 Sep 29;106(9):
pubmed: 25265940
J Clin Oncol. 2018 Nov 10;36(32):3240-3250
pubmed: 30260759
J Clin Oncol. 2012 May 10;30(14):1715-24
pubmed: 22493340
J Am Geriatr Soc. 2016 Sep;64(9):1815-22
pubmed: 27534517
Lancet Oncol. 2018 Nov;19(11):e588-e653
pubmed: 30344075
Int J Chron Obstruct Pulmon Dis. 2019 Jul 31;14:1691-1701
pubmed: 31534323
J Pain Res. 2021 Jun 28;14:1959-1967
pubmed: 34234542
BMC Pulm Med. 2021 May 19;21(1):170
pubmed: 34011344
Mol Oncol. 2020 Aug;14(8):1589-1615
pubmed: 32749074
Health Aff (Millwood). 2011 Mar;30(3):454-63
pubmed: 21383364
World Health Organ Tech Rep Ser. 1990;804:1-75
pubmed: 1702248
Arch Intern Med. 2010 Mar 22;170(6):515-8
pubmed: 20233800
Nat Rev Cancer. 2020 May;20(5):274-284
pubmed: 32235902
J Palliat Care. 2018 Apr;33(2):109-114
pubmed: 29514555
Psychooncology. 2015 Dec;24(12):1731-7
pubmed: 25959002
JAMA Oncol. 2015 Nov;1(8):1051-9
pubmed: 26270597
J Immunother Cancer. 2019 Nov 6;7(1):286
pubmed: 31694698
Cell. 2010 Aug 20;142(4):531-43
pubmed: 20723755
Support Care Cancer. 2013 Mar;21(3):659-85
pubmed: 22936493
J Clin Oncol. 2006 Jul 20;24(21):3490-6
pubmed: 16849766
Oncologist. 2011;16(1):105-11
pubmed: 21212438
J Clin Med. 2020 Nov 30;9(12):
pubmed: 33265959
Psychooncology. 2021 Nov;30(11):1876-1883
pubmed: 34157174
Cancer. 2009 May 1;115(9):2013-21
pubmed: 19235253
Mol Cancer Ther. 2011 Sep;10(9):1667-76
pubmed: 21750223
Am J Hosp Palliat Care. 2021 Nov;38(11):1378-1390
pubmed: 33423532
Ann Palliat Med. 2021 May;10(5):5923-5930
pubmed: 32279519
Crit Care Clin. 2021 Jan;37(1):151-174
pubmed: 33190767
JAMA. 2017 Jul 11;318(2):197-198
pubmed: 28586821
Cancer Res. 2015 May 1;75(9):1777-81
pubmed: 25795709
BMC Palliat Care. 2016 Jul 08;15:56
pubmed: 27391378
Cochrane Database Syst Rev. 2017 Jun 12;6:CD011129
pubmed: 28603881
J Palliat Care. 2014 Winter;30(4):321-6
pubmed: 25962270
J Natl Cancer Inst. 2015 Oct 12;107(12):djv274
pubmed: 26464423
Front Oncol. 2019 May 01;9:337
pubmed: 31119099
Clin Nutr. 2021 May;40(5):2898-2913
pubmed: 33946039
J Clin Oncol. 2014 May 10;32(14):1480-501
pubmed: 24711559
J Palliat Med. 2020 Nov;23(11):1460-1467
pubmed: 32286904
BMC Palliat Care. 2020 Jun 1;19(1):76
pubmed: 32482172
World J Urol. 2019 Dec;37(12):2549-2555
pubmed: 30382379
Front Cell Dev Biol. 2020 Dec 17;8:601738
pubmed: 33392191
Health Qual Life Outcomes. 2006 Oct 11;4:79
pubmed: 17034633
J Clin Oncol. 2015 Feb 1;33(4):370-6
pubmed: 25534384
Autoimmun Rev. 2020 Aug;19(8):102586
pubmed: 32535094
J Palliat Med. 2018 May;21(5):694-699
pubmed: 29658821
JAMA. 2013 Feb 27;309(8):814-22
pubmed: 23443445
Palliat Med. 1993;7(2):93-100
pubmed: 7505177
NIH Consens State Sci Statements. 2002 Jul 15-17;19(4):1-29
pubmed: 14984106
Acta Oncol. 2017 Sep;56(9):1168-1174
pubmed: 28524711
J Ethnopharmacol. 2020 Oct 5;260:113066
pubmed: 32505837
Lancet Oncol. 2018 Dec;19(12):1579-1589
pubmed: 30442497
J Clin Oncol. 2011 Feb 20;29(6):755-60
pubmed: 21263086
Hematol Oncol. 2020 Oct;38(4):565-575
pubmed: 32383782
Nat Rev Clin Oncol. 2016 Mar;13(3):159-71
pubmed: 26598947